FAM127A Inhibitors
Chemical inhibitors of FAM127A can exert their inhibitory effects through various molecular pathways. Staurosporine operates as a broad-spectrum protein kinase inhibitor, impeding the phosphorylation processes vital for many proteins, including FAM127A. This inhibition can prevent FAM127A from undergoing necessary post-translational modifications that activate or facilitate its function. LY294002 and Wortmannin, both specific inhibitors of PI3K, can disrupt the PI3K/AKT pathway, a crucial signaling route that can influence the function of numerous proteins, FAM127A being one of them. By impeding this pathway, these inhibitors can alter the activity of FAM127A, which may depend on signals propagated through PI3K.
Inhibitors like Rapamycin and PP2 target mTOR and Src family tyrosine kinases, respectively. Rapamycin's inhibition of mTOR can lead to a cascade effect, hindering the function of proteins involved in mTOR signaling, which can include FAM127A. PP2's inhibition of Src kinases can similarly disrupt signaling pathways that oversee cell growth and differentiation, potentially affecting the normal function of FAM127A. MEK inhibitors, such as PD98059 and U0126, prevent the activation of the MAPK/ERK pathway. Since this pathway is integral to cell proliferation and differentiation, the inhibition of MEK can indirectly affect proteins that are part of this signaling cascade, such as FAM127A. Similarly, SP600125 and SB203580, which inhibit JNK and p38 MAP kinase respectively, can impede the MAPK pathway's stress response and inflammatory signaling, potentially impacting FAM127A's activity. Lastly, Bafilomycin A1's inhibition of V-ATPase proton pump can disrupt vesicular acidification, affecting endo-lysosomal trafficking or sorting processes, which can be crucial for the proper localization and function of FAM127A. Chemicals such as ML141 and NSC23766, which target Cdc42 and Rac1 GTPases, can affect the actin cytoskeleton organization and cellular processes such as migration or endocytosis, processes that FAM127A may regulate or participate in.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Given that FAM127A is a protein, staurosporine can inhibit its function by blocking the phosphorylation processes that are essential for the protein's activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 specifically inhibits PI3K, which is involved in signal transduction pathways that regulate cell growth and survival, possibly intersecting with FAM127A's pathway or function, leading to its inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key kinase that regulates cell growth and proliferation. Inhibition of mTOR can lead to the inhibition of downstream proteins that rely on mTOR signaling, which may include FAM127A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is part of the MAPK/ERK pathway. Inhibition of MEK can prevent the activation of downstream proteins that could be necessary for FAM127A's function, thereby inhibiting it. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK pathway. By inhibiting JNK, SP600125 can prevent the activation of proteins involved in stress response and apoptosis that may be functionally related to FAM127A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, it can disrupt the signaling pathways that regulate inflammatory responses and cell differentiation, which could be crucial for FAM127A's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, it can alter the PI3K/AKT pathway and potentially inhibit downstream proteins that are involved in the same pathway or process as FAM127A. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, which are part of the MAPK/ERK pathway. Inhibiting MEK1/2 can prevent the phosphorylation of ERK and subsequent activation of proteins that may interact with or be necessary for FAM127A activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. By inhibiting Src kinases, it can inhibit signaling pathways involved in cell growth and differentiation that FAM127A may be a part of. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 specifically inhibits the V-ATPase proton pump, leading to disruption of vesicle acidification. This inhibition can interfere with endo-lysosomal sorting or trafficking pathways that FAM127A might be involved with. | ||||||